NDC 51662-1289
Atropine Sulfate 0.1 mg per 1 mL injection, solution
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Hospira, Inc.'s NDC 0409-1630.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- Dec 21, 2023 · Class I · Pfizer Inc.
Presence of Particulate Matter; identified as glass
Lots: Lot GY2496, Exp 02/01/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Atropine: every company that makes it
- Form
- injection, solution, endotracheal; intramuscular; intravenous; subcutaneous
- Strength
- 0.1 mg per 1 mL
- Approval
- NDA NDA021146
- On the market since
- Sep 23, 2018
- Package NDCs
51662-1289-151662-1289-251662-1289-3- Official label
- DailyMed (National Library of Medicine), updated Jun 19, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?